<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:11:03Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8811711" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8811711</identifier>
        <datestamp>2022-02-09</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Psychiatry</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Psychiatry</journal-id>
              <journal-title-group>
                <journal-title>JAMA Psychiatry</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2168-622X</issn>
              <issn pub-type="epub">2168-6238</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8811711</article-id>
              <article-id pub-id-type="pmcid">PMC8811711</article-id>
              <article-id pub-id-type="pmc-uid">8811711</article-id>
              <article-id pub-id-type="pmid">35107563</article-id>
              <article-id pub-id-type="pmid">35107563</article-id>
              <article-id pub-id-type="doi">10.1001/jamapsychiatry.2021.4225</article-id>
              <article-id pub-id-type="publisher-id">yoi210085</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="domain" specific-use="print">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="featured" specific-use="electronic">
                  <subject>Featured</subject>
                </subj-group>
                <subj-group subj-group-type="online-first">
                  <subject>Online First</subject>
                </subj-group>
                <subj-group subj-group-type="allowCommenting">
                  <subject>Comments</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation</article-title>
                <subtitle>A Randomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Association of Anxiety With Autonomic Hypersensitivity and Ventromedial Prefrontal Cortex Activity</alt-title>
                <alt-title alt-title-type="running-head">Association of Anxiety With Autonomic Hypersensitivity and Ventromedial Prefrontal Cortex Activity</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Teed</surname>
                    <given-names>Adam R.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Feinstein</surname>
                    <given-names>Justin S.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Puhl</surname>
                    <given-names>Maria</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lapidus</surname>
                    <given-names>Rachel C.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Upshaw</surname>
                    <given-names>Valerie</given-names>
                  </name>
                  <degrees>BSN</degrees>
                  <degrees>NP</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kuplicki</surname>
                    <given-names>Rayus T.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bodurka</surname>
                    <given-names>Jerzy</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="yoi210085aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ajijola</surname>
                    <given-names>Olujimi A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kaye</surname>
                    <given-names>Walter H.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="yoi210085aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thompson</surname>
                    <given-names>Wesley K.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Paulus</surname>
                    <given-names>Martin P.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="yoi210085aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="yoi210085aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Khalsa</surname>
                    <given-names>Sahib S.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>PhD</degrees>
                  <xref rid="yoi210085aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="yoi210085aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="yoi210085aff1"><label>1</label>Laureate Institute for Brain Research, Tulsa, Oklahoma</aff>
              <aff id="yoi210085aff2"><label>2</label>Stephenson School for Biomedical Engineering, University of Oklahoma, Norman</aff>
              <aff id="yoi210085aff3"><label>3</label>Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, California</aff>
              <aff id="yoi210085aff4"><label>4</label>Department of Psychiatry, University of California, San Diego</aff>
              <aff id="yoi210085aff5"><label>5</label>Oxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma</aff>
              <aff id="yoi210085aff6"><label>6</label>Deputy Editor, <italic>JAMA Psychiatry</italic></aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> November 19, 2021.</p>
                <p content-type="published-online"><bold>Published Online:</bold> February 2, 2022. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamapsychiatry.2021.4225</uri></p>
                <p content-type="correction-note"><bold>Correction:</bold> This article was corrected on April 6, 2022, to add Dr Ajijola’s second degree (PhD) to the byline and the Trial Registration information to the end of the Abstract.</p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. © 2022 Teed AR et al. <italic>JAMA Psychiatry</italic>.</p>
                <corresp id="yoi210085cor1"><bold>Corresponding Author:</bold> Sahib S. Khalsa, MD, PhD, Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136 (<email xlink:href="skhalsa@laureateinstitute.org">skhalsa@laureateinstitute.org</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions</bold>: Drs Teed and Khalsa had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the analysis.</p>
                <p><italic>Concept and design:</italic> Paulus, Khalsa.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> Teed, Feinstein, Puhl, Lapidus, Upshaw, Kuplicki, Ajijola, Kaye, Thompson, Paulus, Khalsa.</p>
                <p><italic>Drafting of the manuscript:</italic> Teed, Feinstein, Upshaw, Paulus, Khalsa.</p>
                <p><italic>Critical revision of the manuscript for important intellectual content:</italic> Teed, Puhl, Lapidus, Kuplicki, Ajijola, Kaye, Thompson, Paulus, Khalsa.</p>
                <p><italic>Statistical analysis:</italic> Teed, Puhl, Kuplicki, Thompson, Paulus, Khalsa.</p>
                <p><italic>Obtained funding:</italic> Paulus, Khalsa.</p>
                <p><italic>Administrative, technical, or material support:</italic> Feinstein, Lapidus, Ajijola, Kaye, Khalsa.</p>
                <p><italic>Supervision:</italic> Khalsa.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Ajijola reported having ownership in NeuCures outside the submitted work. Dr Kuplicki reported receiving grants from the National Institute of General Medical Sciences during the conduct of the study. Dr Paulus reported receiving general institutional support from the William K. Warren Foundation and grants from the National Institute of General Medical Sciences during the conduct of the study. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This research was supported by grant K23MH112949 from the National Institute of Mental Health (Dr Khalsa), the Laureate Institute for Brain Research, and grant P20GM121312 from the National Institute of General Medical Sciences (Drs Paulus and Khalsa).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> The data are not available.</p>
                <p><bold>Additional Contributions:</bold> Emily Adamic, MS, assisted with the supplemental figures; Megan Sinik, BS, Dhvanit Raval, BS, and Chloe Sigman, BS, provided physiological data processing assistance; and Megan Cole, RN, Jeanne Echols, RN, Lisa Augustine, RN, Susan Maxey, RN, and Lindsey Bailey, NT, provided isoproterenol preparation assistance. At the time of their involvement with the study, Ms Adamic was a graduate student; Mss Sinik and Sigman and Mr Raval were volunteers; and Mss Cole, Echols, Augustine, Maxey, and Bailey were full-time employees of the Laureate Institute for Brain Research. None of these individuals were paid as contractors or received additional compensation for their contribution to the study beyond regular employment.</p>
                <p><bold>Additional Information:</bold> Coauthor Jerzy Bodurka, PhD, died August 13, 2021.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2022-02-02T10:00">
                <day>2</day>
                <month>2</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ecorrected">
                <day>6</day>
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>2</day>
                <month>2</month>
                <year>2022</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>79</volume>
              <issue>4</issue>
              <fpage>323</fpage>
              <lpage>332</lpage>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2022 Teed AR et al. <italic>JAMA Psychiatry</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamapsychiatry-e214225.pdf">jamapsychiatry-e214225.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archpsyc/fullarticle/10.1001/jamapsychiatry.2021.4225"/>
              <related-article related-article-type="correction-forward" ext-link-type="doi" id="YCX220004" xlink:href="10.1001/jamapsychiatry.2022.0434"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-yoi210085-1">
                  <title>Question</title>
                  <p>Do individuals with generalized anxiety disorder (GAD) show abnormal physiological, perceptual, or neural responses during peripheral β-adrenergic stimulation that may indicate interoceptive dysfunction?</p>
                </sec>
                <sec id="ab-yoi210085-2">
                  <title>Findings</title>
                  <p>In this crossover randomized clinical trial, female patients with GAD exhibited hypersensitivity to adrenergic stimulation as well as greater interoceptive sensation and diminished ventromedial prefrontal cortex activity compared with healthy participants.</p>
                </sec>
                <sec id="ab-yoi210085-3">
                  <title>Meaning</title>
                  <p>This study provides evidence of dysfunctional autonomic and central nervous system contributions to the pathophysiology of GAD and suggests that the ventromedial prefrontal cortex may be a treatment target.</p>
                </sec>
              </abstract>
              <abstract>
                <sec id="ab-yoi210085-4">
                  <title>Importance</title>
                  <p>β-Adrenergic stimulation elicits heart palpitations and dyspnea, key features of acute anxiety and sympathetic arousal, yet no neuroimaging studies have examined how the pharmacologic modulation of interoceptive signals is associated with fear-related neurocircuitry in individuals with generalized anxiety disorder (GAD).</p>
                </sec>
                <sec id="ab-yoi210085-5">
                  <title>Objective</title>
                  <p>To examine the neural circuitry underlying autonomic arousal induced via isoproterenol, a rapidly acting, peripheral β-adrenergic agonist akin to adrenaline.</p>
                </sec>
                <sec id="ab-yoi210085-6">
                  <title>Design, Setting, and Participants</title>
                  <p>This crossover randomized clinical trial of 58 women with artifact-free data was conducted from January 1, 2017, to November 31, 2019, at the Laureate Institute for Brain Research in Tulsa, Oklahoma.</p>
                </sec>
                <sec id="ab-yoi210085-7">
                  <title>Exposures</title>
                  <p>Functional magnetic resonance imaging was used to assess neural responses during randomized intravenous bolus infusions of isoproterenol (0.5 and 2.0 μg) and saline, each administered twice in a double-blind fashion.</p>
                </sec>
                <sec id="ab-yoi210085-8">
                  <title>Main Outcomes and Measures</title>
                  <p>Blood oxygen level–dependent responses across the whole brain during isoproterenol administration in patients with GAD vs healthy comparators. Cardiac and respiratory responses, as well as interoceptive awareness and anxiety, were also measured during the infusion protocol.</p>
                </sec>
                <sec id="ab-yoi210085-9">
                  <title>Results</title>
                  <p>Of the 58 female study participants, 29 had GAD (mean [SD] age, 26.9 [6.8] years) and 29 were matched healthy comparators (mean [SD] age, 24.4 [5.0] years). During the 0.5-μg dose of isoproterenol, the GAD group exhibited higher heart rate responses (<italic>b</italic> = 5.34; 95% CI, 2.06-8.61; <italic>P</italic> = .002), higher intensity ratings of cardiorespiratory sensations (<italic>b</italic> = 8.38; 95% CI, 2.05-14.71; <italic>P</italic> = .01), higher levels of self-reported anxiety (<italic>b</italic> = 1.04; 95% CI, 0.33-1.76; <italic>P</italic> = .005), and significant hypoactivation in the ventromedial prefrontal cortex (vmPFC) that was evident throughout peak response (Cohen <italic>d</italic> = 1.55; <italic>P</italic> &lt; .001) and early recovery (Cohen <italic>d</italic> = 1.52; <italic>P</italic> &lt; .001) periods. Correlational analysis of physiological and subjective indexes and percentage of signal change extracted during the 0.5-μg dose revealed that vmPFC hypoactivation was inversely correlated with heart rate (<italic>r</italic><sub>56</sub> = −0.51, adjusted <italic>P</italic> = .001) and retrospective intensity of both heartbeat (<italic>r</italic><sub>56</sub> = −0.50, adjusted <italic>P</italic> = .002) and breathing (<italic>r</italic><sub>56</sub> = −0.44, adjusted <italic>P</italic> = .01) sensations. Ventromedial prefrontal cortex hypoactivation correlated inversely with continuous dial ratings at a trend level (<italic>r</italic><sub>56</sub> = −0.38, adjusted <italic>P</italic> = .051), whereas anxiety (<italic>r</italic><sub>56</sub> = −0.28, adjusted <italic>P</italic> = .27) and chronotropic dose 25 (<italic>r</italic><sub>56</sub> = −0.14, adjusted <italic>P</italic> = .72) showed no such association.</p>
                </sec>
                <sec id="ab-yoi210085-10">
                  <title>Conclusions and Relevance</title>
                  <p>In this crossover randomized clinical trial, women with GAD exhibited autonomic hypersensitivity during low levels of adrenergic stimulation characterized by elevated heart rate, heightened interoceptive awareness, increased anxiety, and a blunted neural response localized to the vmPFC. These findings support the notion that autonomic hyperarousal may be associated with regulatory dysfunctions in the vmPFC, which could serve as a treatment target to help patients with GAD more appropriately appraise and regulate signals of sympathetic arousal.</p>
                </sec>
                <sec id="ab-yoi210085-11">
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov Identifier: <ext-link xlink:href="https://www.clinicaltrials.gov/ct2/show/NCT02615119?term=NCT02615119&amp;draw=2&amp;rank=1" ext-link-type="uri">NCT02615119</ext-link></p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This crossover randomized clinical trial of individuals with generalized anxiety disorder examines the association between abnormal physiological, perceptual, or neural responses during peripheral β-adrenergic stimulation and interoceptive dysfunction.</p>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-YOI210085">
              <title>Introduction</title>
              <p>Generalized anxiety disorder (GAD), the most common clinical manifestation of anxiety,<sup><xref rid="yoi210085r1" ref-type="bibr">1</xref></sup> is characterized by excessive, uncontrollable anxiety and worry persisting for at least 6 months. Patients with GAD frequently show resistance to pharmacotherapy<sup><xref rid="yoi210085r2" ref-type="bibr">2</xref></sup> and psychotherapy,<sup><xref rid="yoi210085r3" ref-type="bibr">3</xref></sup> making it one of the most difficult anxiety disorders to treat.<sup><xref rid="yoi210085r4" ref-type="bibr">4</xref>,<xref rid="yoi210085r5" ref-type="bibr">5</xref></sup> Generalized anxiety disorder affects nearly twice as many women as men,<sup><xref rid="yoi210085r6" ref-type="bibr">6</xref></sup> and comorbidities with depression, substance use, and other anxiety disorders are common.<sup><xref rid="yoi210085r4" ref-type="bibr">4</xref>,<xref rid="yoi210085r7" ref-type="bibr">7</xref></sup> Hyperarousal symptoms are often experienced by individuals with GAD,<sup><xref rid="yoi210085r8" ref-type="bibr">8</xref></sup> including restlessness, feeling keyed up or on edge, muscle tension, and insomnia.<sup><xref rid="yoi210085r9" ref-type="bibr">9</xref></sup> Patients with GAD also seek cardiologic evaluation for autonomic arousal symptoms at the same rate as those with panic disorder,<sup><xref rid="yoi210085r10" ref-type="bibr">10</xref></sup> but such symptoms (eg, accelerated heart rate [HR], shortness of breath, and sweating) do not consistently correlate with peripheral autonomic indexes in ambulatory studies.<sup><xref rid="yoi210085r11" ref-type="bibr">11</xref></sup> Consequently, their perception of physiological arousal is often mismatched with their actual physiological state,<sup><xref rid="yoi210085r12" ref-type="bibr">12</xref></sup> suggesting that interoceptive dysfunction is a characteristic feature of the disorder.<sup><xref rid="yoi210085r13" ref-type="bibr">13</xref></sup> Identifying substrates of this dysfunction that are involved in disease-modifying processes could provide novel targets for treatments that may help to overcome the high levels of anxious relapse and resistance to existing treatments.</p>
              <p>The neural basis for anxious arousal in GAD is unclear and has not received much attention as a treatment target despite recent recommendations that modeling anxiety in humans by combining anxiety-induction procedures with neurocircuit measures provides “a key intermediate bridge between basic and clinical sciences.”<sup><xref rid="yoi210085r14" ref-type="bibr">14</xref></sup> Accordingly, we designed a pharmacologic protocol capable of eliciting a full range of physiological arousal responses in the cardiovascular and pulmonary systems using bolus intravenous infusions of isoproterenol, a fast-acting adrenaline analog.<sup><xref rid="yoi210085r15" ref-type="bibr">15</xref></sup> Isoproterenol induces transient stimulation of peripheral β<sub>1</sub>- and β<sub>2</sub>-adrenergic receptors,<sup><xref rid="yoi210085r16" ref-type="bibr">16</xref></sup> yielding reliable dose-dependent cardiorespiratory modulation that returns to baseline within minutes.<sup><xref rid="yoi210085r15" ref-type="bibr">15</xref></sup> It also has minimal blood-brain barrier penetration, making it a good probe for selectively modulating the body and measuring the afferent response inside the brain.<sup><xref rid="yoi210085r17" ref-type="bibr">17</xref>,<xref rid="yoi210085r18" ref-type="bibr">18</xref>,<xref rid="yoi210085r19" ref-type="bibr">19</xref></sup> The bolus form of administration is safe and tolerable, even in clinically anxious populations.<sup><xref rid="yoi210085r20" ref-type="bibr">20</xref>,<xref rid="yoi210085r21" ref-type="bibr">21</xref></sup> Human lesion models have revealed a network of brain regions, including the insular and medial prefrontal cortices (PFCs)<sup><xref rid="yoi210085r22" ref-type="bibr">22</xref></sup> and the amygdala,<sup><xref rid="yoi210085r23" ref-type="bibr">23</xref></sup> that are critical for generating awareness of isoproterenol-induced sensations. We adapted the infusion protocol to the neuroimaging environment and demonstrated that the insular cortex is the primary region responding during isoproterenol-induced stimulation in healthy comparators (HCs) at a 2.0-μg dose.<sup><xref rid="yoi210085r18" ref-type="bibr">18</xref>,<xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> These functional magnetic resonance imaging (fMRI) results are corroborated by similar positron emission tomography<sup><xref rid="yoi210085r25" ref-type="bibr">25</xref></sup> findings.</p>
              <p>This study used a multilevel approach to test the hypothesis that patients with GAD compared with HCs show exaggerated, dose-related subjective, physiological, and neural responses to adrenergic stimulation with isoproterenol. Support for this hypothesis would provide evidence for dysautonomia in GAD, which could be targeted in the future to develop novel interventions. To date, no functional neuroimaging studies have exposed clinically anxious individuals to isoproterenol. We hypothesized that patients with GAD would show a hypersensitivity to isoproterenol characterized by elevations in HR, interoceptive awareness of cardiorespiratory sensations, and levels of anxiety; we expected to see such differences emerge starting at a 0.5-μg dose level. On the basis of previous fMRI studies,<sup><xref rid="yoi210085r18" ref-type="bibr">18</xref>,<xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> we anticipated that this physiological and subjective hypersensitivity in GAD would be reflected by heightened neural responses in the insular cortex.</p>
            </sec>
            <sec id="H1-2-YOI210085">
              <title>Methods</title>
              <sec id="H2-1-YOI210085">
                <title>Participants</title>
                <p>Diagnostic grouping of participants in this crossover randomized clinical trial was based on <italic>DSM-IV</italic> or <italic>DSM-5</italic> criteria using the Mini-International Neuropsychiatric Interview.<sup><xref rid="yoi210085r26" ref-type="bibr">26</xref></sup> Additional inclusion criteria required patients with GAD to have scores greater than 7 and 10, respectively, on the Overall Anxiety Severity and Impairment Scale<sup><xref rid="yoi210085r27" ref-type="bibr">27</xref></sup> and GAD-7<sup><xref rid="yoi210085r28" ref-type="bibr">28</xref></sup> scale, indicative of clinically significant anxiety. Current or prior cardiorespiratory illness, including asthma, or other major psychiatric disorders (eMethods 1 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>) were exclusionary. Although comorbid depression and anxiety disorders were allowed, panic disorder was exclusionary to reduce potential dropout associated with isoproterenol-induced panic anxiety.<sup><xref rid="yoi210085r29" ref-type="bibr">29</xref></sup> Selected psychotropic agents were allowed provided there was no change in dosage 4 weeks before the MRI. Demographic matching variables included self-reported sex, age, and measured body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared). Self-reported race and ethnicity were recorded as required by the funding agency. All study procedures were approved by the Western Institutional Review Board, and all participants provided written informed consent before participation. This study followed the Consolidated Standards of Reporting Trials (<ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link>) reporting guideline (study protocol is given in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 2</xref>), and data were collected from January 1, 2017, to November 31, 2019, at the Laureate Institute for Brain Research, Tulsa, Oklahoma.</p>
              </sec>
              <sec id="H2-2-YOI210085">
                <title>Experimental Protocols</title>
                <p>We measured parametric physiological and blood oxygen level–dependent (BOLD) changes during randomized, double-blind intravenous bolus infusions of isoproterenol hydrochloride (0.5 and 2 μg) or saline administered 60 seconds into each MRI infusion scan (eFigure 1 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). Each infusion condition was repeated once for a total of 6 infusion scans administered via a randomized crossover procedure (eMethods 2 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). Cardiac and respiration waveforms were measured simultaneously with fMRI using, respectively, a pulse oximeter attached to a nondominant finger and a thoracic respiration belt, both sampled at 40 Hz. Participants continuously rated changes in perceived cardiorespiratory intensity by rotating an MRI-compatible dial (Current Designs Inc) with their dominant hand throughout each 240-second scan using a visual analog scale ranging from 0 (none or normal) to 10 (most ever) (eFigure 2 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). After each infusion, participants retrospectively reported their perceived cardiac and respiratory sensation intensity as well as anxiety and excitement using an 11-point scale.<sup><xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> Before the MRI session, we administered 2 single-blind infusions (saline and 1.0 μg of isoproterenol) to familiarize participants with the infusion procedure (eMethods 2 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
              <sec id="H2-3-YOI210085">
                <title>Behavioral and Physiological Analysis</title>
                <p>We indirectly estimated β-adrenergic receptor sensitivity for each participant by calculating the chronotropic dose 25 (CD25), a standard parameter that reflects the dose required to increase HR by 25/min<sup><xref rid="yoi210085r16" ref-type="bibr">16</xref></sup> according to the formula provided by Mills et al.<sup><xref rid="yoi210085r30" ref-type="bibr">30</xref></sup> We tested for group differences in CD25 via 2-tailed, independent <italic>t</italic> test. Interoceptive detection rates were assessed via χ<sup>2</sup> test (eMethods 3 and eFigure 4 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). We used linear mixed-effects regression to examine epoch effects of group and dose on HR, respiratory volume variability, respiratory results (reported in eResults 1, eFigure 3, and eTable 5 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>), interoceptive awareness (continuous dial ratings, retrospective heartbeat intensity, and respiratory intensity ratings), and retrospective anxiety and excitement ratings. Fixed effects for group (HCs and patients with GAD) and dose were included for post-MRI ratings and cross-correlations between HR and dial ratings (eMethods 3, eResults 2, eFigure 6, and eTables 6 and 7 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>) as well as their second-level interactions. All linear mixed-effects models included fixed effects for participant age, BMI, and their group variable interaction (eMethods 3 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
              <sec id="H2-4-YOI210085">
                <title>MRI Data Acquisition</title>
                <p>We acquired anatomical, T1-weighted, magnetization-prepared, rapid gradient-echo sequence images and T2*-weighted BOLD contrast images via an echoplanar sequence in a 3-T scanner with an 8-channel head coil (GE MR750; GE Healthcare) (eMethods 4 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
              <sec id="H2-5-YOI210085">
                <title>fMRI Analysis</title>
                <p>Data preprocessing and analyses were performed in AFNI.<sup><xref rid="yoi210085r31" ref-type="bibr">31</xref></sup> Preprocessing steps included despiking, slice time correction, spatial smoothing (6-mm full width at half maximum gaussian kernel), coregistation to the first volume, and normalization to Talairach space (eMethods 5 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). Temporal fluctuations of cardiac and respiratory frequencies and their first-order harmonics were removed from the BOLD signal using RETROICOR<sup><xref rid="yoi210085r32" ref-type="bibr">32</xref></sup> implemented via custom code in MATLAB (MathWorks).<sup><xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> Individual-level percentage of signal change (PSC) maps of BOLD response to cardiorespiratory stimulation were generated from residual images by contrasting epoch-averaged signals for isoproterenol against the baseline period (first 45 seconds) preceding each infusion. On the basis of previous studies,<sup><xref rid="yoi210085r18" ref-type="bibr">18</xref>,<xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> we defined 4 discrete epochs of interest as follows (eFigure 1 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>): the anticipatory period (20 seconds) after infusion delivery but preceding the onset of isoproterenol effects, the peak effect period (40 seconds), and early (60 seconds) and late (62 seconds) recovery periods. We performed whole-brain voxelwise <italic>t</italic> tests contrasting group-averaged PSC maps for each epoch to examine potential differences between the GAD and HC groups using <italic>3dttest</italic>++ in AFNI (eMethods 6 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). In addition, to better understand how the temporal dynamics of isoproterenol’s effects on BOLD response, HR, and sensation rating trajectories might differ between the GAD and HC groups without predefining epochs, we performed a multivariate, sparse functional principal components analysis. Methodologic details for this technique can be found in eMethods 7 and eFigure 7, and the results are found in eResults 4, eFigure 8, and eTables 8-12 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p>
              </sec>
              <sec id="H2-6-YOI210085">
                <title>Multilevel Correlational Analysis and Linear Modeling of Outcomes</title>
                <p>To assess dimensional associations between outcomes, we conducted post hoc, multiple comparison–corrected Pearson correlations across diagnostic groups for cardiorespiratory, subjective (continuous or retrospective), and neural responses (eMethods 3 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). To evaluate whether diagnostic group affects the associations between outcome variables, we tested for differences in slopes estimated by linear models. Specifically, we generated linear models for BOLD PSC activity and HR or subjective dial responses in the form of lm(PSC − HR × group) and evaluated the interaction term.</p>
              </sec>
            </sec>
            <sec id="H1-3-YOI210085">
              <title>Results</title>
              <p>Of the 58 female study participants, 29 had GAD (mean [SD] age, 26.9 [6.8] years) and 29 were matched HCs (mean [SD] age, 24.4 [5.0] years) based on self-reported age and measured BMI (<xref rid="yoi210085t1" ref-type="table">Table</xref> and <xref rid="yoi210085f1" ref-type="fig">Figure 1</xref>; eTable 1 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). The GAD group reported greater retrospective intensity of both heartbeat (estimate [SE] <italic>b</italic> = 2.21 [0.44]; 95% CI, 1.35-3.07; <italic>t</italic><sub>278.81</sub> = 5.04; <italic>P</italic> &lt; .001) and breathing sensations (estimate [SE] <italic>b</italic> = 1.51 [0.41]; 95% CI, 0.72-2.32; <italic>t</italic><sub>276</sub> = 3.70; <italic>P</italic> &lt; .001) during 0.5-μg infusions (<xref rid="yoi210085f2" ref-type="fig">Figure 2</xref>C and D). Anxiety ratings for those with GAD were also significantly greater than HCs at both the 0.5-μg dose (estimate [SE] <italic>b</italic> = 1.04 [0.37]; 95% CI, 0.33-1.76; <italic>t</italic><sub>281.32</sub> = 2.84; <italic>P</italic> = .005) and 2.0-μg dose (estimate [SE] <italic>b</italic> = 1.22 [0.36]; 95% CI, 0.51-1.94; <italic>t</italic><sub>281.11</sub> = 3.36; <italic>P</italic> =  001) doses (<xref rid="yoi210085f2" ref-type="fig">Figure 2</xref>F), whereas no main or interaction effects were seen for excitement at either dose (eTable 4 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              <table-wrap position="float" id="yoi210085t1">
                <label>Table. </label>
                <caption>
                  <title>Descriptive and Inferential Statistics for Demographic and Diagnostic Variables</title>
                </caption>
                <table frame="hsides" rules="groups">
                  <col width="12.01%" span="1"/>
                  <col width="32.08%" span="1"/>
                  <col width="16.36%" span="1"/>
                  <col width="29.01%" span="1"/>
                  <col width="10.54%" span="1"/>
                  <thead>
                    <tr>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th>
                      <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Mean (SD)</th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>t</italic> Value (<italic>df</italic>)</th>
                      <th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th>
                    </tr>
                    <tr>
                      <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Patients with GAD (n = 29)</th>
                      <th valign="top" align="left" scope="col" rowspan="1" colspan="1">HCs (n = 29)</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">26.9 (6.8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">24.4 (5.0)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1.61 (51.62)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">.11</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">BMI</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">25.64 (4.59)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">24.04 (3.12)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1.55 (49.33)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">.13</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">GAD-7</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">13.52 (3.41)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1.03 (1.52)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">−18.01 (38.76)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">OASIS</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">10.79 (2.23)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1.17 (1.56)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">−19.06 (50.16)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">ASI-3</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">27.62 (14.46)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">7.55 (4.26)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"> −7.17 (32.82)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" scope="row" rowspan="1" colspan="1">PHQ-9</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">11.21 (4.95)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">0.72 (1.10)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">−11.13 (30.75)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">&lt;.001</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <p>Abbreviations: ASI-3, Anxiety Sensitivity Index 3; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); GAD, Generalized Anxiety Disorder; GAD-7, 7-item Generalized Anxiety Disorder scale; HCs, healthy comparators, OASIS, Overall Anxiety Severity and Impairment Scale; PHQ-9, 9-item Patient Health Questionnaire.</p>
                </table-wrap-foot>
              </table-wrap>
              <fig position="float" id="yoi210085f1" fig-type="figure">
                <label>Figure 1. </label>
                <caption>
                  <title>CONSORT Diagram</title>
                  <p>BMI indicates body mass index; EEG, electroencephalography; GAD, generalized anxiety disorder; HC, healthy comparator; and MRI, magnetic resonance imaging.</p>
                </caption>
                <graphic xlink:href="jamapsychiatry-e214225-g001" position="float"/>
              </fig>
              <fig position="float" id="yoi210085f2" fig-type="figure">
                <label>Figure 2. </label>
                <caption>
                  <title>Physiological, Perceptual, and Affective Responses During Isoproterenol and Saline Infusions</title>
                  <p>Box plots are shown representing median (thick line) and 25th and 75th quartiles (thin lines) with whiskers extending to 1.5 × the IQR. Chronotropic dose 25 (CD25) values reflect the dose required to elevate the heart rate by 25/min. GAD indicates general anxiety disorder; HCs, healthy comparators.</p>
                </caption>
                <graphic xlink:href="jamapsychiatry-e214225-g002" position="float"/>
              </fig>
              <p>The GAD group showed greater adrenergic sensitivity to isoproterenol than HCs as indicated by smaller CD25 values (GAD group = 1.17 μg; HC group = 1.61 μg; Cohen <italic>d</italic> = 0.55; 95% CI, 0.02-0.86; <italic>t</italic><sub>54.97</sub> = 2.10; <italic>P</italic> = .04) (<xref rid="yoi210085f2" ref-type="fig">Figure 2</xref>E). Epoch-based linear mixed-effects models for HR suggested that this effect of GAD was driven primarily by sensitivity at the peak of the 0.5-μg dose (estimate [SE] <italic>b</italic> = 5.34 [1.68]; 95% CI, 2.06-8.61; <italic>t</italic><sub>1650.04</sub> = 3.17; <italic>P</italic> = .002; mean GAD HR increase of 13 beats per minute, mean HC HR increase of 7 beats per minute) (<xref rid="yoi210085f2" ref-type="fig">Figure 2</xref>B; eTable 2 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>), which corresponded with greater perception of cardiorespiratory intensity during the peak (estimate [SE] <italic>b</italic> = 8.38 [3.26]; 95% CI, 2.05-14.71; <italic>t</italic><sub>1650.55</sub> = 2.57; <italic>P</italic> = .01) and early recovery (estimate [SE] <italic>b</italic> = 9.11 [3.26]; 95% CI, 2.77-15.45; <italic>t</italic><sub>1650.04</sub> = 2.80; <italic>P</italic> = .005) periods (<xref rid="yoi210085f2" ref-type="fig">Figure 2</xref>A; eTable 3 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              <p>Whole-brain results are reported at the <italic>P</italic> &lt; .001 level with a 5% false-positive rate cluster correction. In alignment with the physiological observations of dose-specific hypersensitivity, we observed significant group differences during the peak and early recovery epochs during the 0.5-μg but not 2.0-μg infusions (<xref rid="yoi210085f3" ref-type="fig">Figure 3</xref>A and B). Specifically, the GAD group showed significantly decreased BOLD signal changes in 2 clusters during the peak response period: the bilateral ventromedial prefrontal cortex (vmPFC) extending to the rostral anterior cingulate cortex (ACC) (k = 601, center of mass: x = −6.9, y = 44.6, z = 0.1; Cohen <italic>d</italic> = 1.55; <italic>P</italic> &lt; .001) and the left angular gyrus extending into the precuneus (k = 246, center of mass: x = −37, y = −65.3, z = 36.2) (eFigure 5 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). During the early recovery period, the vmPFC again showed greater attenuation for the GAD group (k = 779, center of mass: x = −2.2, y = 45.2, z = 1.4; Cohen <italic>d</italic> = 1.52; <italic>P</italic> &lt; .001). The whole-brain analysis revealed no other significant regional group differences during any other epoch but identified effects of dose for the insular cortex across all participants. This dose-dependent activation was found bilaterally in the ventral mid insula during the peak and early recovery epochs relative to the preinfusion baseline at both 0.5 and 2.0 μg (<xref rid="yoi210085f4" ref-type="fig">Figure 4</xref>). Potential effects of medication status on the linear mixed-effects models were assessed by generating models for the whole-brain, physiological, and subjective responses after removing the 6 medicated patients of the GAD group. For each response modality, similar group differences were observed at the 0.5-μg dose in the unmedicated GAD subgroup (eResults 3 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              <fig position="float" id="yoi210085f3" fig-type="figure">
                <label>Figure 3. </label>
                <caption>
                  <title>Group Differences in Ventromedial Prefrontal Cortex Response From Whole-Brain Analyses</title>
                  <p>A, Significant group activation differences during the peak response period were only found during administration of the 0.5-μg dose at a voxelwise threshold of <italic>P</italic> &lt; .001 and a 95% false-positive rate cluster correction. B, Significant group activation differences during the early recovery period were only found during administration of the 0.5-μg dose. Right insets show the percentage of signal change above baseline for each dose. C, Mean activitation time course for the significant ventromedial prefrontal cortex (vmPFC) region (blue cluster from peak period) identified during the 0.5-μg infusion. Shaded lines indicate SEMs. BOLD indicates blood oxygenation level–dependent response; GAD, generalized anxiety disorder; and HC, healthy comparator.</p>
                </caption>
                <graphic xlink:href="jamapsychiatry-e214225-g003" position="float"/>
              </fig>
              <fig position="float" id="yoi210085f4" fig-type="figure">
                <label>Figure 4. </label>
                <caption>
                  <title>Insular Cortex Responses During Isoproterenol and Saline Infusion</title>
                  <p>A, Increased activity localized within bilateral clusters of ventral insular cortex was observed across all participants via voxelwise, whole-brain analysis during the peak effect epoch of the 2.0-μg isoproterenol infusion. B, No significant differences were found between groups within the ventral insular cortex clusters at each dose. The 2.0-μg infusion elicited a significantly larger insula response than the saline and the 0.5-μg infusion. The clusters identified at 2.0 μg were used as masks for extracting signal change for each dose and the saline infusions based on prior studies<sup><xref rid="yoi210085r18" ref-type="bibr">18</xref>,<xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> in which the 2.0-μg dose proved to be sensitive at eliciting insula activity in healthy individuals. C, Cohen <italic>d</italic> effect sizes when comparing each isoproterenol dose with saline. Error bars indicate SEMs. GAD indicates generalized anxiety disorder; HC, healthy comparator.</p>
                </caption>
                <graphic xlink:href="jamapsychiatry-e214225-g004" position="float"/>
              </fig>
              <p>Correlational analysis of physiological and subjective indexes and PSC extracted during the 0.5-μg dose revealed that vmPFC hypoactivation was inversely correlated with HR (<italic>r</italic><sub>56</sub> = −0.51, adjusted <italic>P</italic> = .001) and retrospective intensity of both heartbeat (<italic>r</italic><sub>56</sub> = −0.5, adjusted <italic>P</italic> = .002) and breathing (<italic>r</italic><sub>56</sub> = −0.44, adjusted <italic>P</italic> = .01) sensations. The vmPFC hypoactivation correlated inversely with dial ratings at a trend level (<italic>r</italic><sub>56</sub> = −0.38, adjusted <italic>P</italic> = .051), whereas anxiety (<italic>r</italic><sub>56</sub> = −0.28, adjusted <italic>P</italic> = .27) or CD25 (<italic>r</italic><sub>56</sub> = −0.14, adjusted <italic>P</italic> = .72) showed no such association (eFigure 9 and eTable 13 in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>). Evaluation of group differences in slopes estimated by linear models of the associations between voxelwise vmPFC PSC and either HR (estimate [SE] <italic>b</italic> = −0.02 [0.01]; <italic>t</italic><sub>54</sub> = −1.73; <italic>P</italic> = .09) or subjective dial response (estimate [SE] <italic>b</italic> = −0.01 [0.01]; <italic>t</italic><sub>54</sub> = −0.66; <italic>P</italic> = .51) indicated that the associations between these outcomes were not affected by group.</p>
            </sec>
            <sec id="H1-4-YOI210085">
              <title>Discussion</title>
              <p>We used peripheral β-adrenergic stimulation with isoproterenol to evaluate physiological, subjective, and neural responses during fMRI in women with GAD compared with HCs. As expected, this manipulation evoked dose-dependent increases in cardiorespiratory parameters across all participants. However, the GAD group exhibited hypersensitivity to the lower dose of isoproterenol across all response modalities. Specifically, during the peak window of the 0.5-μg dose, the GAD group demonstrated significant elevations in HR while also reporting significantly more intense cardiorespiratory sensations during this dose and significantly more anxiety than HCs during both doses. Whole-brain fMRI analyses revealed significant group differences only during the 0.5-μg infusion, with the GAD group exhibiting bilateral vmPFC hypoactivation throughout the peak and early recovery epochs and left inferior parietal cortex hypoactivation during the peak epoch compared with HCs. Of note, vmPFC activation differences were moderately to strongly correlated with HR and cardiorespiratory self-report during the 0.5-μg infusion. The lack of group differences in physiological or neural responses to saline or the 2.0-μg infusion highlighted the GAD group’s sensitivity to sympathetic arousal signals during lower levels of adrenergic stimulation.</p>
              <p>The present experimental medicine findings provide novel evidence of autonomic and central nervous system contributions to the interoceptive pathophysiological mechanisms of GAD. Although sympathetic hyperarousal has not been prominently associated with GAD in ambulatory or laboratory studies,<sup><xref rid="yoi210085r11" ref-type="bibr">11</xref>,<xref rid="yoi210085r33" ref-type="bibr">33</xref>,<xref rid="yoi210085r34" ref-type="bibr">34</xref></sup> such studies did not rely on parametric receptor stimulation. Lower CD25 values in the GAD group suggest a greater peripheral β-adrenergic receptor density, which could explain their exaggerated physiological response to adrenergic stimulation (ie, a left-shifted drug potency effect). At this dose, we also saw altered brain responses in the vmPFC, a key node of the central autonomic network<sup><xref rid="yoi210085r35" ref-type="bibr">35</xref>,<xref rid="yoi210085r36" ref-type="bibr">36</xref></sup> with multisynaptic connections to viscerosensory and visceromotor autonomic ganglia.<sup><xref rid="yoi210085r37" ref-type="bibr">37</xref></sup> The blunted vmPFC activation together with the exaggerated self-reported and physiological responses support the idea that a lack of top-down regulation in the presence of a bottom-up sympathetic nervous system stimulation elicits an internal state that further promotes an anxious response. Cortical thinning of this area has been seen in patients with GAD compared with HCs and was positively correlated with worry and trait anxiety across groups.<sup><xref rid="yoi210085r38" ref-type="bibr">38</xref></sup> The vmPFC and ACC are highly connected with the dorsolateral PFC and have been observed to be inhibited by worry induction.<sup><xref rid="yoi210085r39" ref-type="bibr">39</xref></sup> This circuit could help to explain the chronic high-anxiety state typical in GAD.</p>
              <p>Because no group differences were found in vmPFC hypoactivation at high doses, the effect at low doses may also represent a dysfunctional central regulatory threshold<sup><xref rid="yoi210085r40" ref-type="bibr">40</xref>,<xref rid="yoi210085r41" ref-type="bibr">41</xref>,<xref rid="yoi210085r42" ref-type="bibr">42</xref></sup> in GAD. These neural effects cannot be entirely attributable to a greater propensity of patients with GAD to focus their attention on cardiorespiratory sensations because no significant between-group differences were found in brain activation during the saline condition. Despite the causal nature of our peripheral afferent manipulation, pinpointing the propagation and controllers of homeostatic signals through the afferent and efferent limbs of the brain-body (ie, cybernetic<sup><xref rid="yoi210085r43" ref-type="bibr">43</xref>,<xref rid="yoi210085r44" ref-type="bibr">44</xref></sup>) feedback loop remains challenging. Computational models of homeostatic and allostatic interoceptive regulation<sup><xref rid="yoi210085r45" ref-type="bibr">45</xref></sup> reflect one approach for differentiating sensory inputs from selected actions via incorporation of hierarchical precision-weighted predictions and prediction errors.<sup><xref rid="yoi210085r46" ref-type="bibr">46</xref></sup> Thus, whether the GAD group’s more vigorous reaction to lower levels of stimulation stems from abnormal peripheral inputs (ie, overabundance of cardiovascular β-adrenergic receptors), aberrant visceromotor responses (ie, a dysfunctional central controller), or interacting peripheral and central processes awaits determination.</p>
              <p>To our knowledge, this is the first neuroimaging study to examine how the direct modulation of interoceptive signals influences fear-related (ie, vmPFC) neurocircuitry in individuals with clinical anxiety. Converging lesion<sup><xref rid="yoi210085r47" ref-type="bibr">47</xref>,<xref rid="yoi210085r48" ref-type="bibr">48</xref>,<xref rid="yoi210085r49" ref-type="bibr">49</xref></sup> and functional neuroimaging<sup><xref rid="yoi210085r50" ref-type="bibr">50</xref>,<xref rid="yoi210085r51" ref-type="bibr">51</xref>,<xref rid="yoi210085r52" ref-type="bibr">52</xref></sup> evidence implicates the vmPFC in the regulation of negative affect and worry, including the suppression and spontaneous recovery of fear.<sup><xref rid="yoi210085r53" ref-type="bibr">53</xref>,<xref rid="yoi210085r54" ref-type="bibr">54</xref>,<xref rid="yoi210085r55" ref-type="bibr">55</xref></sup> Further work has suggested that the vmPFC provides a signal<sup><xref rid="yoi210085r56" ref-type="bibr">56</xref></sup> that previously threatening stimuli may be reconsidered as safe.<sup><xref rid="yoi210085r57" ref-type="bibr">57</xref></sup> Indeed, the portion of the vmPFC we found to have the most disruption during low levels of adrenergic stimulation overlaps with the region most correlated with safety.<sup><xref rid="yoi210085r58" ref-type="bibr">58</xref></sup> In addition, vmPFC hypoactivity is related to difficulty discerning safety from threat,<sup><xref rid="yoi210085r59" ref-type="bibr">59</xref></sup> deficient top-down control in individuals with anxiety during threat-related distractors,<sup><xref rid="yoi210085r60" ref-type="bibr">60</xref></sup> abnormal emotion processing across psychiatric disorders,<sup><xref rid="yoi210085r61" ref-type="bibr">61</xref></sup> and worry severity in GAD.<sup><xref rid="yoi210085r52" ref-type="bibr">52</xref></sup> Of note, “categorizing and assigning value to interoceptive sensations through the filter of one’s autobiographical narrative”<sup><xref rid="yoi210085r62" ref-type="bibr">62</xref></sup> is a key attributional process theorized to be mediated by the vmPFC. Our results may thus reflect a deficient self-appraisal capacity in GAD to adaptively assign meaning during interoceptively driven anxious arousal. This argument is supported by the vmPFC’s role in regulating the physiological state of the body based on self-relevant contexts.<sup><xref rid="yoi210085r63" ref-type="bibr">63</xref>,<xref rid="yoi210085r64" ref-type="bibr">64</xref></sup> Potential clinical applications from this work include pharmacologic or neuromodulation targeting of vmPFC responses (eg, via real-time fMRI neurofeedback or transcranial focused ultrasonography) to determine their effect on anxious rumination in GAD.</p>
              <p>The insula was activated in both groups during isoproterenol infusions, consistent with an insular mapping of cardiorespiratory states,<sup><xref rid="yoi210085r24" ref-type="bibr">24</xref></sup> although, contrary to our expectations, we did not observe significant group differences. Given the exaggerated perceptual and physiological responses observed in GAD, perhaps dysfunction within the vmPFC led to failures to appropriately appraise sympathetic arousal signals from the insula, which could have contributed to their heightened reports of anxiety. This explanation seems plausible given that the vmPFC assigns valence to different states of arousal,<sup><xref rid="yoi210085r62" ref-type="bibr">62</xref>,<xref rid="yoi210085r65" ref-type="bibr">65</xref></sup> particularly through its reciprocal anatomical connections with the insula,<sup><xref rid="yoi210085r66" ref-type="bibr">66</xref></sup> the primary cortical recipient of afferent viscerosensory signals.<sup><xref rid="yoi210085r67" ref-type="bibr">67</xref>,<xref rid="yoi210085r68" ref-type="bibr">68</xref>,<xref rid="yoi210085r69" ref-type="bibr">69</xref></sup> Indeed, previous studies<sup><xref rid="yoi210085r70" ref-type="bibr">70</xref>,<xref rid="yoi210085r71" ref-type="bibr">71</xref></sup> have shown reduced functional connectivity between both regions in individuals with anxiety under resting conditions. Thus, dysregulation within vmPFC-to-insula neurocircuitry may entail a failure to constrain sympathetic arousal signals, resulting in downstream consequences, such as increased worry, rumination, and anxiety<sup><xref rid="yoi210085r72" ref-type="bibr">72</xref></sup>; such a process has been observed during periods of sympathetic arousal associated with anxious rumination.<sup><xref rid="yoi210085r73" ref-type="bibr">73</xref>,<xref rid="yoi210085r74" ref-type="bibr">74</xref></sup></p>
              <sec id="H2-7-YOI210085">
                <title>Limitations</title>
                <p>This study has limitations, including the limited number of participants, a female-only sample, and psychotropic medication allowance (eDiscussion in <xref rid="note-YOI210085-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
            </sec>
            <sec id="H1-5-YOI210085">
              <title>Conclusions</title>
              <p>In this crossover randomized clinical trial, women with GAD showed autonomic hypersensitivity during low levels of adrenergic stimulation characterized by an elevated HR, heightened interoceptive awareness, increased anxiety, and a blunted neural response localized to the vmPFC. Autonomic hyperarousal may be linked to regulatory dysfunctions in the vmPFC, which could serve as a treatment target to help patients with anxiety more appropriately appraise and regulate sympathetic arousal signals emanating from the autonomic nervous system.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-YOI210085">
              <title>References</title>
              <ref id="yoi210085r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kessler</surname><given-names>RC</given-names></string-name>, <string-name><surname>Wang</surname><given-names>PS</given-names></string-name></person-group>. <article-title>The descriptive epidemiology of commonly occurring mental disorders in the United States</article-title>. <source>Annu Rev Public Health</source>. <year>2008</year>;<volume>29</volume>:<fpage>115</fpage>-<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.publhealth.29.020907.090847</pub-id><?supplied-pmid 18348707?><pub-id pub-id-type="pmid">18348707</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Lorenz</surname><given-names>RA</given-names></string-name>, <string-name><surname>Jackson</surname><given-names>CW</given-names></string-name>, <string-name><surname>Saitz</surname><given-names>M</given-names></string-name></person-group>. <article-title>Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder</article-title>. <source>Pharmacotherapy</source>. <year>2010</year>;<volume>30</volume>(<issue>9</issue>):<fpage>942</fpage>-<lpage>951</lpage>. doi:<pub-id pub-id-type="doi">10.1592/phco.30.9.942</pub-id><?supplied-pmid 20795849?><pub-id pub-id-type="pmid">20795849</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Button</surname><given-names>ML</given-names></string-name>, <string-name><surname>Westra</surname><given-names>HA</given-names></string-name>, <string-name><surname>Hara</surname><given-names>KM</given-names></string-name>, <string-name><surname>Aviram</surname><given-names>A</given-names></string-name></person-group>. <article-title>Disentangling the impact of resistance and ambivalence on therapy outcomes in cognitive behavioural therapy for generalized anxiety disorder</article-title>. <source>Cogn Behav Ther</source>. <year>2015</year>;<volume>44</volume>(<issue>1</issue>):<fpage>44</fpage>-<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1080/16506073.2014.959038</pub-id><?supplied-pmid 25277366?><pub-id pub-id-type="pmid">25277366</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fava</surname><given-names>M</given-names></string-name>, <string-name><surname>Rush</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Alpert</surname><given-names>JE</given-names></string-name>, <etal/></person-group>. <article-title>Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report</article-title>. <source>Am J Psychiatry</source>. <year>2008</year>;<volume>165</volume>(<issue>3</issue>):<fpage>342</fpage>-<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2007.06111868</pub-id><?supplied-pmid 18172020?><pub-id pub-id-type="pmid">18172020</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Olatunji</surname><given-names>BO</given-names></string-name>, <string-name><surname>Cisler</surname><given-names>JM</given-names></string-name>, <string-name><surname>Deacon</surname><given-names>BJ</given-names></string-name></person-group>. <article-title>Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings</article-title>. <source>Psychiatr Clin North Am</source>. <year>2010</year>;<volume>33</volume>(<issue>3</issue>):<fpage>557</fpage>-<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psc.2010.04.002</pub-id><?supplied-pmid 20599133?><pub-id pub-id-type="pmid">20599133</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r6">
                <label>6</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Craske</surname><given-names>MG</given-names></string-name></person-group>. <source>Origins of Phobias and Anxiety Disorders: Why More Women Than Men?</source><publisher-name>Elsevier</publisher-name>; <year>2003</year>.</mixed-citation>
              </ref>
              <ref id="yoi210085r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Grant</surname><given-names>BF</given-names></string-name>, <string-name><surname>Hasin</surname><given-names>DS</given-names></string-name>, <string-name><surname>Stinson</surname><given-names>FS</given-names></string-name>, <etal/></person-group>. <article-title>Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions</article-title>. <source>Psychol Med</source>. <year>2005</year>;<volume>35</volume>(<issue>12</issue>):<fpage>1747</fpage>-<lpage>1759</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291705006069</pub-id><?supplied-pmid 16202187?><pub-id pub-id-type="pmid">16202187</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Roth</surname><given-names>WT</given-names></string-name>, <string-name><surname>Doberenz</surname><given-names>S</given-names></string-name>, <string-name><surname>Dietel</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Sympathetic activation in broadly defined generalized anxiety disorder</article-title>. <source>J Psychiatr Res</source>. <year>2008</year>;<volume>42</volume>(<issue>3</issue>):<fpage>205</fpage>-<lpage>212</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2006.12.003</pub-id><?supplied-pmid 17250853?><pub-id pub-id-type="pmid">17250853</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r9">
                <label>9</label>
                <mixed-citation publication-type="book"><person-group><collab>American Psychiatric Association</collab></person-group>. <source>Diagnostic and Statistical Manual of Mental Disorders</source>. <edition>5th ed</edition>. <publisher-name>American Psychiatric Association</publisher-name>; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="yoi210085r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Logue</surname><given-names>MB</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>AM</given-names></string-name>, <string-name><surname>Barbee</surname><given-names>JG</given-names></string-name>, <etal/></person-group>. <article-title>Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder</article-title>. <source>J Psychiatr Res</source>. <year>1993</year>;<volume>27</volume>(<issue>1</issue>):<fpage>55</fpage>-<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0022-3956(93)90049-8</pub-id><?supplied-pmid 8515389?><pub-id pub-id-type="pmid">8515389</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hoehn-Saric</surname><given-names>R</given-names></string-name>, <string-name><surname>McLeod</surname><given-names>DR</given-names></string-name>, <string-name><surname>Funderburk</surname><given-names>F</given-names></string-name>, <string-name><surname>Kowalski</surname><given-names>P</given-names></string-name></person-group>. <article-title>Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study</article-title>. <source>Arch Gen Psychiatry</source>. <year>2004</year>;<volume>61</volume>(<issue>9</issue>):<fpage>913</fpage>-<lpage>921</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.61.9.913</pub-id><?supplied-pmid 15351770?><pub-id pub-id-type="pmid">15351770</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hoehn-Saric</surname><given-names>R</given-names></string-name>, <string-name><surname>McLeod</surname><given-names>DR</given-names></string-name></person-group>. <article-title>Anxiety and arousal: physiological changes and their perception</article-title>. <source>J Affect Disord</source>. <year>2000</year>;<volume>61</volume>(<issue>3</issue>):<fpage>217</fpage>-<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0165-0327(00)00339-6</pub-id><?supplied-pmid 11163423?><pub-id pub-id-type="pmid">11163423</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Adolphs</surname><given-names>R</given-names></string-name>, <string-name><surname>Cameron</surname><given-names>OG</given-names></string-name>, <etal/>; <collab>Interoception Summit 2016 Participants</collab></person-group>. <article-title>Interoception and mental health: a roadmap</article-title>. <source>Biol Psychiatry Cogn Neurosci Neuroimaging</source>. <year>2018</year>;<volume>3</volume>(<issue>6</issue>):<fpage>501</fpage>-<lpage>513</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpsc.2017.12.004</pub-id><?supplied-pmid 29884281?><pub-id pub-id-type="pmid">29884281</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Grillon</surname><given-names>C</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>OJ</given-names></string-name>, <string-name><surname>Cornwell</surname><given-names>B</given-names></string-name>, <string-name><surname>Ernst</surname><given-names>M</given-names></string-name></person-group>. <article-title>Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences</article-title>. <source>Neuropsychopharmacology</source>. <year>2019</year>;<volume>44</volume>(<issue>12</issue>):<fpage>1999</fpage>-<lpage>2010</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41386-019-0445-1</pub-id><?supplied-pmid 31226707?><pub-id pub-id-type="pmid">31226707</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Rudrauf</surname><given-names>D</given-names></string-name>, <string-name><surname>Sandesara</surname><given-names>C</given-names></string-name>, <string-name><surname>Olshansky</surname><given-names>B</given-names></string-name>, <string-name><surname>Tranel</surname><given-names>D</given-names></string-name></person-group>. <article-title>Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness</article-title>. <source>Int J Psychophysiol</source>. <year>2009</year>;<volume>72</volume>(<issue>1</issue>):<fpage>34</fpage>-<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpsycho.2008.08.010</pub-id><?supplied-pmid 18854201?><pub-id pub-id-type="pmid">18854201</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cleaveland</surname><given-names>CR</given-names></string-name>, <string-name><surname>Rangno</surname><given-names>RE</given-names></string-name>, <string-name><surname>Shand</surname><given-names>DG</given-names></string-name></person-group>. <article-title>A standardized isoproterenol sensitivity test: the effects of sinus arrhythmia, atropine, and propranolol</article-title>. <source>Arch Intern Med</source>. <year>1972</year>;<volume>130</volume>(<issue>1</issue>):<fpage>47</fpage>-<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archinte.1972.03650010035007</pub-id><?supplied-pmid 5035982?><pub-id pub-id-type="pmid">5035982</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Borges</surname><given-names>N</given-names></string-name>, <string-name><surname>Sarmento</surname><given-names>A</given-names></string-name>, <string-name><surname>Azevedo</surname><given-names>I</given-names></string-name></person-group>. <article-title>Dynamics of experimental vasogenic brain oedema in the rat: changes induced by adrenergic drugs</article-title>. <source>J Auton Pharmacol</source>. <year>1999</year>;<volume>19</volume>(<issue>4</issue>):<fpage>209</fpage>-<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2680.1999.00137.x</pub-id><?supplied-pmid 10589971?><pub-id pub-id-type="pmid">10589971</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hassanpour</surname><given-names>MS</given-names></string-name>, <string-name><surname>Yan</surname><given-names>L</given-names></string-name>, <string-name><surname>Wang</surname><given-names>DJ</given-names></string-name>, <etal/></person-group>. <article-title>How the heart speaks to the brain: neural activity during cardiorespiratory interoceptive stimulation</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2016</year>;<volume>371</volume>(<issue>1708</issue>):<fpage>371</fpage>. doi:<pub-id pub-id-type="doi">10.1098/rstb.2016.0017</pub-id><?supplied-pmid 28080974?><pub-id pub-id-type="pmid">28080974</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Murphy</surname><given-names>VA</given-names></string-name>, <string-name><surname>Johanson</surname><given-names>CE</given-names></string-name></person-group>. <article-title>Adrenergic-induced enhancement of brain barrier system permeability to small nonelectrolytes: choroid plexus versus cerebral capillaries</article-title>. <source>J Cereb Blood Flow Metab</source>. <year>1985</year>;<volume>5</volume>(<issue>3</issue>):<fpage>401</fpage>-<lpage>412</lpage>. doi:<pub-id pub-id-type="doi">10.1038/jcbfm.1985.55</pub-id><?supplied-pmid 3928638?><pub-id pub-id-type="pmid">3928638</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Craske</surname><given-names>MG</given-names></string-name>, <string-name><surname>Li</surname><given-names>W</given-names></string-name>, <string-name><surname>Vangala</surname><given-names>S</given-names></string-name>, <string-name><surname>Strober</surname><given-names>M</given-names></string-name>, <string-name><surname>Feusner</surname><given-names>JD</given-names></string-name></person-group>. <article-title>Altered interoceptive awareness in anorexia nervosa: effects of meal anticipation, consumption and bodily arousal</article-title>. <source>Int J Eat Disord</source>. <year>2015</year>;<volume>48</volume>(<issue>7</issue>):<fpage>889</fpage>-<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1002/eat.22387</pub-id><?supplied-pmid 25712775?><pub-id pub-id-type="pmid">25712775</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Hassanpour</surname><given-names>MS</given-names></string-name>, <string-name><surname>Strober</surname><given-names>M</given-names></string-name>, <string-name><surname>Craske</surname><given-names>MG</given-names></string-name>, <string-name><surname>Arevian</surname><given-names>AC</given-names></string-name>, <string-name><surname>Feusner</surname><given-names>JD</given-names></string-name></person-group>. <article-title>interoceptive anxiety and body representation in anorexia nervosa</article-title>. <source>Front Psychiatry</source>. <year>2018</year>;<volume>9</volume>(<issue>444</issue>):<fpage>444</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00444</pub-id><?supplied-pmid 30298026?><pub-id pub-id-type="pmid">30298026</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Rudrauf</surname><given-names>D</given-names></string-name>, <string-name><surname>Feinstein</surname><given-names>JS</given-names></string-name>, <string-name><surname>Tranel</surname><given-names>D</given-names></string-name></person-group>. <article-title>The pathways of interoceptive awareness</article-title>. <source>Nat Neurosci</source>. <year>2009</year>;<volume>12</volume>(<issue>12</issue>):<fpage>1494</fpage>-<lpage>1496</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.2411</pub-id><?supplied-pmid 19881506?><pub-id pub-id-type="pmid">19881506</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name>, <string-name><surname>Feinstein</surname><given-names>JS</given-names></string-name>, <string-name><surname>Li</surname><given-names>W</given-names></string-name>, <string-name><surname>Feusner</surname><given-names>JD</given-names></string-name>, <string-name><surname>Adolphs</surname><given-names>R</given-names></string-name>, <string-name><surname>Hurlemann</surname><given-names>R</given-names></string-name></person-group>. <article-title>Panic anxiety in humans with bilateral amygdala lesions: pharmacological induction via cardiorespiratory interoceptive pathways</article-title>. <source>J Neurosci</source>. <year>2016</year>;<volume>36</volume>(<issue>12</issue>):<fpage>3559</fpage>-<lpage>3566</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4109-15.2016</pub-id><?supplied-pmid 27013684?><pub-id pub-id-type="pmid">27013684</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Hassanpour</surname><given-names>MS</given-names></string-name>, <string-name><surname>Simmons</surname><given-names>WK</given-names></string-name>, <string-name><surname>Feinstein</surname><given-names>JS</given-names></string-name>, <etal/></person-group>. <article-title>The insular cortex dynamically maps changes in cardiorespiratory interoception</article-title>. <source>Neuropsychopharmacology</source>. <year>2018</year>;<volume>43</volume>(<issue>2</issue>):<fpage>426</fpage>-<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2017.154</pub-id><?supplied-pmid 28726799?><pub-id pub-id-type="pmid">28726799</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cameron</surname><given-names>OG</given-names></string-name>, <string-name><surname>Minoshima</surname><given-names>S</given-names></string-name></person-group>. <article-title>Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humans</article-title>. <source>Psychosom Med</source>. <year>2002</year>;<volume>64</volume>(<issue>6</issue>):<fpage>851</fpage>-<lpage>861</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.psy.0000038939.33335.32</pub-id><?supplied-pmid 12461189?><pub-id pub-id-type="pmid">12461189</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Sheehan</surname><given-names>DV</given-names></string-name>, <string-name><surname>Lecrubier</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sheehan</surname><given-names>KH</given-names></string-name>, <etal/></person-group>. <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>J Clin Psychiatry</source>. <year>1998</year>;<volume>59</volume>(<issue>suppl 20</issue>):<fpage>22</fpage>-<lpage>33</lpage>.<?supplied-pmid 9881538?><pub-id pub-id-type="pmid">9881538</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Campbell-Sills</surname><given-names>L</given-names></string-name>, <string-name><surname>Norman</surname><given-names>SB</given-names></string-name>, <string-name><surname>Craske</surname><given-names>MG</given-names></string-name>, <etal/></person-group>. <article-title>Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS)</article-title>. <source>J Affect Disord</source>. <year>2009</year>;<volume>112</volume>(<issue>1-3</issue>):<fpage>92</fpage>-<lpage>101</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2008.03.014</pub-id><?supplied-pmid 18486238?><pub-id pub-id-type="pmid">18486238</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Spitzer</surname><given-names>RL</given-names></string-name>, <string-name><surname>Kroenke</surname><given-names>K</given-names></string-name>, <string-name><surname>Williams</surname><given-names>JBW</given-names></string-name>, <string-name><surname>Löwe</surname><given-names>B</given-names></string-name></person-group>. <article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title>. <source>Arch Intern Med</source>. <year>2006</year>;<volume>166</volume>(<issue>10</issue>):<fpage>1092</fpage>-<lpage>1097</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><?supplied-pmid 16717171?><pub-id pub-id-type="pmid">16717171</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pohl</surname><given-names>R</given-names></string-name>, <string-name><surname>Yeragani</surname><given-names>VK</given-names></string-name>, <string-name><surname>Balon</surname><given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Isoproterenol-induced panic attacks</article-title>. <source>Biol Psychiatry</source>. <year>1988</year>;<volume>24</volume>(<issue>8</issue>):<fpage>891</fpage>-<lpage>902</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0006-3223(88)90224-7</pub-id><?supplied-pmid 3069135?><pub-id pub-id-type="pmid">3069135</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mills</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Dimsdale</surname><given-names>JE</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname><given-names>S</given-names></string-name>, <string-name><surname>Clausen</surname><given-names>J</given-names></string-name>, <string-name><surname>Loredo</surname><given-names>JS</given-names></string-name></person-group>. <article-title>The effects of hypoxia and sleep apnea on isoproterenol sensitivity</article-title>. <source>Sleep</source>. <year>1998</year>;<volume>21</volume>(<issue>7</issue>):<fpage>731</fpage>-<lpage>735</lpage>.<?supplied-pmid 11286349?><pub-id pub-id-type="pmid">11286349</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cox</surname><given-names>RW</given-names></string-name></person-group>. <article-title>AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</article-title>. <source>Comput Biomed Res</source>. <year>1996</year>;<volume>29</volume>(<issue>3</issue>):<fpage>162</fpage>-<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1006/cbmr.1996.0014</pub-id><?supplied-pmid 8812068?><pub-id pub-id-type="pmid">8812068</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Restom</surname><given-names>K</given-names></string-name>, <string-name><surname>Behzadi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname><given-names>TT</given-names></string-name></person-group>. <article-title>Physiological noise reduction for arterial spin labeling functional MRI</article-title>. <source>Neuroimage</source>. <year>2006</year>;<volume>31</volume>(<issue>3</issue>):<fpage>1104</fpage>-<lpage>1115</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.01.026</pub-id><?supplied-pmid 16533609?><pub-id pub-id-type="pmid">16533609</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Klein</surname><given-names>DF</given-names></string-name></person-group>. <article-title>Delineation of two drug-responsive anxiety syndromes</article-title>. <source>Psychopharmacologia</source>. <year>1964</year>;<volume>5</volume>:<fpage>397</fpage>-<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF02193476</pub-id><?supplied-pmid 14194683?><pub-id pub-id-type="pmid">14194683</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Marten</surname><given-names>PA</given-names></string-name>, <string-name><surname>Brown</surname><given-names>TA</given-names></string-name>, <string-name><surname>Barlow</surname><given-names>DH</given-names></string-name>, <string-name><surname>Borkovec</surname><given-names>TD</given-names></string-name>, <string-name><surname>Shear</surname><given-names>MK</given-names></string-name>, <string-name><surname>Lydiard</surname><given-names>RB</given-names></string-name></person-group>. <article-title>Evaluation of the ratings comprising the associated symptom criterion of <italic>DSM-III-R</italic> generalized anxiety disorder</article-title>. <source>J Nerv Ment Dis</source>. <year>1993</year>;<volume>181</volume>(<issue>11</issue>):<fpage>676</fpage>-<lpage>682</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005053-199311000-00005</pub-id><?supplied-pmid 8228949?><pub-id pub-id-type="pmid">8228949</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Benarroch</surname><given-names>EE</given-names></string-name></person-group>. <article-title>The central autonomic network: functional organization, dysfunction, and perspective</article-title>. <source>Mayo Clin Proc</source>. <year>1993</year>;<volume>68</volume>(<issue>10</issue>):<fpage>988</fpage>-<lpage>1001</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0025-6196(12)62272-1</pub-id><?supplied-pmid 8412366?><pub-id pub-id-type="pmid">8412366</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Saper</surname><given-names>CB</given-names></string-name></person-group>. <article-title>The central autonomic nervous system: conscious visceral perception and autonomic pattern generation</article-title>. <source>Annu Rev Neurosci</source>. <year>2002</year>;<volume>25</volume>:<fpage>433</fpage>-<lpage>469</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.neuro.25.032502.111311</pub-id><?supplied-pmid 12052916?><pub-id pub-id-type="pmid">12052916</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r37">
                <label>37</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Saper</surname><given-names>CB</given-names></string-name>, <string-name><surname>Stornetta</surname><given-names>RL</given-names></string-name></person-group>. <part-title>Central autonomic system</part-title>. In: <source>The Rat Nervous System</source>. 4th ed. Elsevier; <year>2015</year>:<fpage>629</fpage>-<lpage>673</lpage>. doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-374245-2.00023-1</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Carnevali</surname><given-names>L</given-names></string-name>, <string-name><surname>Mancini</surname><given-names>M</given-names></string-name>, <string-name><surname>Koenig</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Cortical morphometric predictors of autonomic dysfunction in generalized anxiety disorder</article-title>. <source>Auton Neurosci</source>. <year>2019</year>;<volume>217</volume>:<fpage>41</fpage>-<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.autneu.2019.01.001</pub-id><?supplied-pmid 30704974?><pub-id pub-id-type="pmid">30704974</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Era</surname><given-names>V</given-names></string-name>, <string-name><surname>Carnevali</surname><given-names>L</given-names></string-name>, <string-name><surname>Thayer</surname><given-names>JF</given-names></string-name>, <string-name><surname>Candidi</surname><given-names>M</given-names></string-name>, <string-name><surname>Ottaviani</surname><given-names>C</given-names></string-name></person-group>. <article-title>Dissociating cognitive, behavioral and physiological stress-related responses through dorsolateral prefrontal cortex inhibition</article-title>. <source>Psychoneuroendocrinology</source>. <year>2021</year>;<volume>124</volume>:<elocation-id>105070</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2020.105070</pub-id><?supplied-pmid 33310375?><pub-id pub-id-type="pmid">33310375</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gianaros</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Sheu</surname><given-names>LK</given-names></string-name>, <string-name><surname>Uyar</surname><given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>A brain phenotype for stressor-evoked blood pressure reactivity</article-title>. <source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>(<issue>9</issue>):<elocation-id>e006053</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.117.006053</pub-id><?supplied-pmid 28835356?><pub-id pub-id-type="pmid">28835356</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Shoemaker</surname><given-names>JK</given-names></string-name>, <string-name><surname>Wong</surname><given-names>SW</given-names></string-name>, <string-name><surname>Cechetto</surname><given-names>DF</given-names></string-name></person-group>. <article-title>Cortical circuitry associated with reflex cardiovascular control in humans: does the cortical autonomic network “speak” or “listen” during cardiovascular arousal</article-title>. <source>Anat Rec (Hoboken)</source>. <year>2012</year>;<volume>295</volume>(<issue>9</issue>):<fpage>1375</fpage>-<lpage>1384</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ar.22528</pub-id><?supplied-pmid 22848047?><pub-id pub-id-type="pmid">22848047</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gianaros</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Onyewuenyi</surname><given-names>IC</given-names></string-name>, <string-name><surname>Sheu</surname><given-names>LK</given-names></string-name>, <string-name><surname>Christie</surname><given-names>IC</given-names></string-name>, <string-name><surname>Critchley</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Brain systems for baroreflex suppression during stress in humans</article-title>. <source>Hum Brain Mapp</source>. <year>2012</year>;<volume>33</volume>(<issue>7</issue>):<fpage>1700</fpage>-<lpage>1716</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.21315</pub-id><?supplied-pmid 21567664?><pub-id pub-id-type="pmid">21567664</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r43">
                <label>43</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Ashby</surname><given-names>WR</given-names></string-name></person-group>. <source>An Introduction to Cybernetics</source>. <publisher-name>Chapman &amp; Hall</publisher-name>; <year>1957</year>. doi:<pub-id pub-id-type="doi">10.1063/1.3060436</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Fuster</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Prefrontal cortex and the bridging of temporal gaps in the perception-action cycle</article-title>. <source>Ann N Y Acad Sci</source>. <year>1990</year>;<volume>608</volume>:<fpage>318</fpage>-<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1749-6632.1990.tb48901.x</pub-id><?supplied-pmid 2127512?><pub-id pub-id-type="pmid">2127512</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Petzschner</surname><given-names>FH</given-names></string-name>, <string-name><surname>Garfinkel</surname><given-names>SN</given-names></string-name>, <string-name><surname>Paulus</surname><given-names>MP</given-names></string-name>, <string-name><surname>Koch</surname><given-names>C</given-names></string-name>, <string-name><surname>Khalsa</surname><given-names>SS</given-names></string-name></person-group>. <article-title>Computational models of interoception and body regulation</article-title>. <source>Trends Neurosci</source>. <year>2021</year>;<volume>44</volume>(<issue>1</issue>):<fpage>63</fpage>-<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tins.2020.09.012</pub-id><?supplied-pmid 33378658?><pub-id pub-id-type="pmid">33378658</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Seth</surname><given-names>AK</given-names></string-name>, <string-name><surname>Friston</surname><given-names>KJ</given-names></string-name></person-group>. <article-title>Active interoceptive inference and the emotional brain</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2016</year>;<volume>371</volume>(<issue>1708</issue>):<fpage>371</fpage>. doi:<pub-id pub-id-type="doi">10.1098/rstb.2016.0007</pub-id><?supplied-pmid 28080966?><pub-id pub-id-type="pmid">28080966</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r47">
                <label>47</label>
                <mixed-citation publication-type="book"><person-group><string-name><surname>Damasio</surname><given-names>AR</given-names></string-name></person-group>. <source>Descarte's Error: Emotion, Reason, and the Human Brain</source>. Avon; <year>1994</year>.</mixed-citation>
              </ref>
              <ref id="yoi210085r48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Barrash</surname><given-names>J</given-names></string-name>, <string-name><surname>Tranel</surname><given-names>D</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>SW</given-names></string-name></person-group>. <article-title>Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region</article-title>. <source>Dev Neuropsychol</source>. <year>2000</year>;<volume>18</volume>(<issue>3</issue>):<fpage>355</fpage>-<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1207/S1532694205Barrash</pub-id><?supplied-pmid 11385830?><pub-id pub-id-type="pmid">11385830</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Motzkin</surname><given-names>JC</given-names></string-name>, <string-name><surname>Philippi</surname><given-names>CL</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>RC</given-names></string-name>, <string-name><surname>Baskaya</surname><given-names>MK</given-names></string-name>, <string-name><surname>Koenigs</surname><given-names>M</given-names></string-name></person-group>. <article-title>Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans</article-title>. <source>Biol Psychiatry</source>. <year>2015</year>;<volume>77</volume>(<issue>3</issue>):<fpage>276</fpage>-<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.02.014</pub-id><?supplied-pmid 24673881?><pub-id pub-id-type="pmid">24673881</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Diekhof</surname><given-names>EK</given-names></string-name>, <string-name><surname>Geier</surname><given-names>K</given-names></string-name>, <string-name><surname>Falkai</surname><given-names>P</given-names></string-name>, <string-name><surname>Gruber</surname><given-names>O</given-names></string-name></person-group>. <article-title>Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>58</volume>(<issue>1</issue>):<fpage>275</fpage>-<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.05.073</pub-id><?supplied-pmid 21669291?><pub-id pub-id-type="pmid">21669291</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Makovac</surname><given-names>E</given-names></string-name>, <string-name><surname>Fagioli</surname><given-names>S</given-names></string-name>, <string-name><surname>Rae</surname><given-names>CL</given-names></string-name>, <string-name><surname>Critchley</surname><given-names>HD</given-names></string-name>, <string-name><surname>Ottaviani</surname><given-names>C</given-names></string-name></person-group>. <article-title>Can’t get it off my brain: meta-analysis of neuroimaging studies on perseverative cognition</article-title>. <source>Psychiatry Res Neuroimaging</source>. <year>2020</year>;<volume>295</volume>:<elocation-id>111020</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.pscychresns.2019.111020</pub-id><?supplied-pmid 31790922?><pub-id pub-id-type="pmid">31790922</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Via</surname><given-names>E</given-names></string-name>, <string-name><surname>Fullana</surname><given-names>MA</given-names></string-name>, <string-name><surname>Goldberg</surname><given-names>X</given-names></string-name>, <etal/></person-group>. <article-title>Ventromedial prefrontal cortex activity and pathological worry in generalised anxiety disorder</article-title>. <source>Br J Psychiatry</source>. <year>2018</year>;<volume>213</volume>(<issue>1</issue>):<fpage>437</fpage>-<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1192/bjp.2018.65</pub-id><?supplied-pmid 29739481?><pub-id pub-id-type="pmid">29739481</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Milad</surname><given-names>MR</given-names></string-name>, <string-name><surname>Quirk</surname><given-names>GJ</given-names></string-name></person-group>. <article-title>Neurons in medial prefrontal cortex signal memory for fear extinction</article-title>. <source>Nature</source>. <year>2002</year>;<volume>420</volume>(<issue>6911</issue>):<fpage>70</fpage>-<lpage>74</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature01138</pub-id><?supplied-pmid 12422216?><pub-id pub-id-type="pmid">12422216</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Milad</surname><given-names>MR</given-names></string-name>, <string-name><surname>Wright</surname><given-names>CI</given-names></string-name>, <string-name><surname>Orr</surname><given-names>SP</given-names></string-name>, <string-name><surname>Pitman</surname><given-names>RK</given-names></string-name>, <string-name><surname>Quirk</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Rauch</surname><given-names>SL</given-names></string-name></person-group>. <article-title>Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert</article-title>. <source>Biol Psychiatry</source>. <year>2007</year>;<volume>62</volume>(<issue>5</issue>):<fpage>446</fpage>-<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.10.011</pub-id><?supplied-pmid 17217927?><pub-id pub-id-type="pmid">17217927</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Quirk</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Russo</surname><given-names>GK</given-names></string-name>, <string-name><surname>Barron</surname><given-names>JL</given-names></string-name>, <string-name><surname>Lebron</surname><given-names>K</given-names></string-name></person-group>. <article-title>The role of ventromedial prefrontal cortex in the recovery of extinguished fear</article-title>. <source>J Neurosci</source>. <year>2000</year>;<volume>20</volume>(<issue>16</issue>):<fpage>6225</fpage>-<lpage>6231</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-16-06225.2000</pub-id><?supplied-pmid 10934272?><pub-id pub-id-type="pmid">10934272</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Harrison</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Fullana</surname><given-names>MA</given-names></string-name>, <string-name><surname>Via</surname><given-names>E</given-names></string-name>, <etal/></person-group>. <article-title>Human ventromedial prefrontal cortex and the positive affective processing of safety signals</article-title>. <source>Neuroimage</source>. <year>2017</year>;<volume>152</volume>:<fpage>12</fpage>-<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.02.080</pub-id><?supplied-pmid 28254509?><pub-id pub-id-type="pmid">28254509</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Schiller</surname><given-names>D</given-names></string-name>, <string-name><surname>Levy</surname><given-names>I</given-names></string-name>, <string-name><surname>Niv</surname><given-names>Y</given-names></string-name>, <string-name><surname>LeDoux</surname><given-names>JE</given-names></string-name>, <string-name><surname>Phelps</surname><given-names>EA</given-names></string-name></person-group>. <article-title>From fear to safety and back: reversal of fear in the human brain</article-title>. <source>J Neurosci</source>. <year>2008</year>;<volume>28</volume>(<issue>45</issue>):<fpage>11517</fpage>-<lpage>11525</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2265-08.2008</pub-id><?supplied-pmid 18987188?><pub-id pub-id-type="pmid">18987188</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Tashjian</surname><given-names>SM</given-names></string-name>, <string-name><surname>Zbozinek</surname><given-names>TD</given-names></string-name>, <string-name><surname>Mobbs</surname><given-names>D</given-names></string-name></person-group>. <article-title>A decision architecture for safety computations</article-title>. <source>Trends Cogn Sci</source>. <year>2021</year>;<volume>25</volume>(<issue>5</issue>):<fpage>342</fpage>-<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tics.2021.01.013</pub-id><?supplied-pmid 33674206?><pub-id pub-id-type="pmid">33674206</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Greenberg</surname><given-names>T</given-names></string-name>, <string-name><surname>Carlson</surname><given-names>JM</given-names></string-name>, <string-name><surname>Cha</surname><given-names>J</given-names></string-name>, <string-name><surname>Hajcak</surname><given-names>G</given-names></string-name>, <string-name><surname>Mujica-Parodi</surname><given-names>LR</given-names></string-name></person-group>. <article-title>Ventromedial prefrontal cortex reactivity is altered in generalized anxiety disorder during fear generalization</article-title>. <source>Depress Anxiety</source>. <year>2013</year>;<volume>30</volume>(<issue>3</issue>):<fpage>242</fpage>-<lpage>250</lpage>. doi:<pub-id pub-id-type="doi">10.1002/da.22016</pub-id><?supplied-pmid 23139148?><pub-id pub-id-type="pmid">23139148</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Bishop</surname><given-names>S</given-names></string-name>, <string-name><surname>Duncan</surname><given-names>J</given-names></string-name>, <string-name><surname>Brett</surname><given-names>M</given-names></string-name>, <string-name><surname>Lawrence</surname><given-names>AD</given-names></string-name></person-group>. <article-title>Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli</article-title>. <source>Nat Neurosci</source>. <year>2004</year>;<volume>7</volume>(<issue>2</issue>):<fpage>184</fpage>-<lpage>188</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn1173</pub-id><?supplied-pmid 14703573?><pub-id pub-id-type="pmid">14703573</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>McTeague</surname><given-names>LM</given-names></string-name>, <string-name><surname>Rosenberg</surname><given-names>BM</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>JW</given-names></string-name>, <etal/></person-group>. <article-title>Identification of common neural circuit disruptions in emotional processing across psychiatric disorders</article-title>. <source>Am J Psychiatry</source>. <year>2020</year>;<volume>177</volume>(<issue>5</issue>):<fpage>411</fpage>-<lpage>421</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2019.18111271</pub-id><?supplied-pmid 31964160?><pub-id pub-id-type="pmid">31964160</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Dixon</surname><given-names>ML</given-names></string-name>, <string-name><surname>Thiruchselvam</surname><given-names>R</given-names></string-name>, <string-name><surname>Todd</surname><given-names>R</given-names></string-name>, <string-name><surname>Christoff</surname><given-names>K</given-names></string-name></person-group>. <article-title>Emotion and the prefrontal cortex: an integrative review</article-title>. <source>Psychol Bull</source>. <year>2017</year>;<volume>143</volume>(<issue>10</issue>):<fpage>1033</fpage>-<lpage>1081</lpage>. doi:<pub-id pub-id-type="doi">10.1037/bul0000096</pub-id><?supplied-pmid 28616997?><pub-id pub-id-type="pmid">28616997</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Koban</surname><given-names>L</given-names></string-name>, <string-name><surname>Gianaros</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Kober</surname><given-names>H</given-names></string-name>, <string-name><surname>Wager</surname><given-names>TD</given-names></string-name></person-group>. <article-title>The self in context: brain systems linking mental and physical health</article-title>. <source>Nat Rev Neurosci</source>. <year>2021</year>;<volume>22</volume>(<issue>5</issue>):<fpage>309</fpage>-<lpage>322</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41583-021-00446-8</pub-id><?supplied-pmid 33790441?><pub-id pub-id-type="pmid">33790441</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Babo-Rebelo</surname><given-names>M</given-names></string-name>, <string-name><surname>Richter</surname><given-names>CG</given-names></string-name>, <string-name><surname>Tallon-Baudry</surname><given-names>C</given-names></string-name></person-group>. <article-title>Neural responses to heartbeats in the default network encode the self in spontaneous thoughts</article-title>. <source>J Neurosci</source>. <year>2016</year>;<volume>36</volume>(<issue>30</issue>):<fpage>7829</fpage>-<lpage>7840</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0262-16.2016</pub-id><?supplied-pmid 27466329?><pub-id pub-id-type="pmid">27466329</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Chikazoe</surname><given-names>J</given-names></string-name>, <string-name><surname>Lee</surname><given-names>DH</given-names></string-name>, <string-name><surname>Kriegeskorte</surname><given-names>N</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>AK</given-names></string-name></person-group>. <article-title>Population coding of affect across stimuli, modalities and individuals</article-title>. <source>Nat Neurosci</source>. <year>2014</year>;<volume>17</volume>(<issue>8</issue>):<fpage>1114</fpage>-<lpage>1122</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.3749</pub-id><?supplied-pmid 24952643?><pub-id pub-id-type="pmid">24952643</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mesulam</surname><given-names>MM</given-names></string-name>, <string-name><surname>Mufson</surname><given-names>EJ</given-names></string-name></person-group>. <article-title>Insula of the old world monkey. III: efferent cortical output and comments on function</article-title>. <source>J Comp Neurol</source>. <year>1982</year>;<volume>212</volume>(<issue>1</issue>):<fpage>38</fpage>-<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.902120104</pub-id><?supplied-pmid 7174907?><pub-id pub-id-type="pmid">7174907</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Craig</surname><given-names>AD</given-names></string-name></person-group>. <article-title>How do you feel? interoception: the sense of the physiological condition of the body</article-title>. <source>Nat Rev Neurosci</source>. <year>2002</year>;<volume>3</volume>(<issue>8</issue>):<fpage>655</fpage>-<lpage>666</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn894</pub-id><?supplied-pmid 12154366?><pub-id pub-id-type="pmid">12154366</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cameron</surname><given-names>OG</given-names></string-name></person-group>. <article-title>Interoception: the inside story—a model for psychosomatic processes</article-title>. <source>Psychosom Med</source>. <year>2001</year>;<volume>63</volume>(<issue>5</issue>):<fpage>697</fpage>-<lpage>710</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00006842-200109000-00001</pub-id><?supplied-pmid 11573016?><pub-id pub-id-type="pmid">11573016</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Critchley</surname><given-names>HD</given-names></string-name>, <string-name><surname>Wiens</surname><given-names>S</given-names></string-name>, <string-name><surname>Rotshtein</surname><given-names>P</given-names></string-name>, <string-name><surname>Ohman</surname><given-names>A</given-names></string-name>, <string-name><surname>Dolan</surname><given-names>RJ</given-names></string-name></person-group>. <article-title>Neural systems supporting interoceptive awareness</article-title>. <source>Nat Neurosci</source>. <year>2004</year>;<volume>7</volume>(<issue>2</issue>):<fpage>189</fpage>-<lpage>195</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn1176</pub-id><?supplied-pmid 14730305?><pub-id pub-id-type="pmid">14730305</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Stein</surname><given-names>MB</given-names></string-name>, <string-name><surname>Simmons</surname><given-names>AN</given-names></string-name>, <string-name><surname>Feinstein</surname><given-names>JS</given-names></string-name>, <string-name><surname>Paulus</surname><given-names>MP</given-names></string-name></person-group>. <article-title>Increased amygdala and insula activation during emotion processing in anxiety-prone subjects</article-title>. <source>Am J Psychiatry</source>. <year>2007</year>;<volume>164</volume>(<issue>2</issue>):<fpage>318</fpage>-<lpage>327</lpage>. doi:<pub-id pub-id-type="doi">10.1176/ajp.2007.164.2.318</pub-id><?supplied-pmid 17267796?><pub-id pub-id-type="pmid">17267796</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r71">
                <label>71</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cui</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B</given-names></string-name>, <string-name><surname>Li</surname><given-names>W</given-names></string-name>, <etal/></person-group>. <article-title>Insula shows abnormal task-evoked and resting-state activity in first-episode drug-naïve generalized anxiety disorder</article-title>. <source>Depress Anxiety</source>. <year>2020</year>;<volume>37</volume>(<issue>7</issue>):<fpage>632</fpage>-<lpage>644</lpage>. doi:<pub-id pub-id-type="doi">10.1002/da.23009</pub-id><?supplied-pmid 32196828?><pub-id pub-id-type="pmid">32196828</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r72">
                <label>72</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Makovac</surname><given-names>E</given-names></string-name>, <string-name><surname>Watson</surname><given-names>DR</given-names></string-name>, <string-name><surname>Meeten</surname><given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>Amygdala functional connectivity as a longitudinal biomarker of symptom changes in generalized anxiety</article-title>. <source>Soc Cogn Affect Neurosci</source>. <year>2016</year>;<volume>11</volume>(<issue>11</issue>):<fpage>1719</fpage>-<lpage>1728</lpage>. doi:<pub-id pub-id-type="doi">10.1093/scan/nsw091</pub-id><?supplied-pmid 27369066?><pub-id pub-id-type="pmid">27369066</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r73">
                <label>73</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Makovac</surname><given-names>E</given-names></string-name>, <string-name><surname>Meeten</surname><given-names>F</given-names></string-name>, <string-name><surname>Watson</surname><given-names>DR</given-names></string-name>, <etal/></person-group>. <article-title>Alterations in amygdala-prefrontal functional connectivity account for excessive worry and autonomic dysregulation in generalized anxiety disorder</article-title>. <source>Biol Psychiatry</source>. <year>2016</year>;<volume>80</volume>(<issue>10</issue>):<fpage>786</fpage>-<lpage>795</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.10.013</pub-id><?supplied-pmid 26682467?><pub-id pub-id-type="pmid">26682467</pub-id></mixed-citation>
              </ref>
              <ref id="yoi210085r74">
                <label>74</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Ottaviani</surname><given-names>C</given-names></string-name>, <string-name><surname>Thayer</surname><given-names>JF</given-names></string-name>, <string-name><surname>Verkuil</surname><given-names>B</given-names></string-name>, <etal/></person-group>. <article-title>Physiological concomitants of perseverative cognition: a systematic review and meta-analysis</article-title>. <source>Psychol Bull</source>. <year>2016</year>;<volume>142</volume>(<issue>3</issue>):<fpage>231</fpage>-<lpage>259</lpage>. doi:<pub-id pub-id-type="doi">10.1037/bul0000036</pub-id><?supplied-pmid 26689087?><pub-id pub-id-type="pmid">26689087</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-YOI210085-1">
              <supplementary-material id="note-YOI210085-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p><bold>eMethods 1.</bold> Participants</p>
                  <p><bold>eMethods 2.</bold> Experimental Protocol</p>
                  <p><bold>eMethods 3.</bold> Primary and Exploratory Behavioral and Physiological Data Analysis</p>
                  <p><bold>eMethods 4.</bold> MRI Data Acquisition</p>
                  <p><bold>eMethods 5.</bold> fMRI Preprocessing</p>
                  <p><bold>eMethods 6.</bold> Whole-Brain fMRI Group Analysis</p>
                  <p><bold>eMethods 7.</bold> Longitudinal Time Series Analysis With Regions of Interest</p>
                  <p><bold>eFigure 1.</bold> Infusion Epochs Used in the Isoproterenol fMRI Analysis</p>
                  <p><bold>eFigure 2.</bold> Subjective Response Assessment</p>
                  <p><bold>eFigure 3.</bold> Respiratory Volume Variability During Isoproterenol Infusion</p>
                  <p><bold>eFigure 4.</bold> Interoceptive Detection Rates</p>
                  <p><bold>eFigure 5.</bold> Group Difference in Left Parietal Cortex Activity</p>
                  <p><bold>eFigure 6</bold>. Maximum Cross-correlations Between Heart Rate and Dial Response by Dose in Unmedicated GAD Relative to HC</p>
                  <p><bold>eFigure 7.</bold> Overlap Between Whole-Brain vmPFC Cluster and Meta-analysis–Derived ROIs</p>
                  <p><bold>eFigure 8.</bold> Multivariate Sparse Functional Principal Component Analysis (mSFPCA) Model Fits to Raw Data by Dose and Group</p>
                  <p><bold>eFigure 9.</bold> vmPFC PSC Correlations With Cardiorespiratory and Subjective Variables During the Peak Effect at 0.5μg Isoproterenol</p>
                  <p><bold>eResults 1.</bold> Respiratory Volume Variability (RVV)</p>
                  <p><bold>eResults 2.</bold> Interoceptive Awareness: Detection and Accuracy Measures</p>
                  <p><bold>eResults 3</bold>. Reanalysis of Primary Outcomes With Medicated Participants Removed</p>
                  <p><bold>eResults 4</bold>. Longitudinal Time-Series Analysis</p>
                  <p><bold>eTable 1.</bold> Diagnostic Comorbidities and Psychotropic Medication Status of Generalized Anxiety Disorder and Healthy Comparator Participants</p>
                  <p><bold>eTable 2.</bold> LME for Mean Heart Rate by Group and Dose for Selected Isoproterenol Time-Course Epochs</p>
                  <p><bold>eTable 3.</bold> LME for Continuous Cardiorespiratory Dial Ratings by Group and Dose for Selected Isoproterenol Time-Course Epochs</p>
                  <p><bold>eTable 4.</bold> LME for Retrospective Ratings by Group and Dose</p>
                  <p><bold>eTable 5.</bold> LME for Respiratory Volume Variability by Group and Dose for Selected Isoproterenol Time-Course Epochs</p>
                  <p><bold>eTable 6.</bold> LME for Cross Correlations (CC) Between Real-Time Dial Responses and Heart Rate</p>
                  <p><bold>eTable 7.</bold> LME for Cross Correlations (CC) Between Continuous Dial Responses and Respiratory Volume Variability</p>
                  <p><bold>eTable 8.</bold> LMEs for FPC Score Reflecting Signal Change Timeseries for Meta-analysis–Derived vmPFC ROIs</p>
                  <p><bold>eTable 9.</bold> LME for Mean BOLD PSC for the Meta-analysis–Derived Autonomic vmPFC ROI</p>
                  <p><bold>eTable 10.</bold> LME for BOLD PSC for the Meta-analysis–Derived Self-processing vmPFC ROI</p>
                  <p><bold>eTable 11.</bold> LME for BOLD PSC for the Meta-analysis–Derived Valence vmPFC ROI</p>
                  <p><bold>eTable 12.</bold> LMEs for Heart Rate and Dial Response FPC Scores</p>
                  <p><bold>eTable 13.</bold> Multilevel Correlations Between vmPFC Activity, Cardiac, and Subjective Responses During 0.5μg Isoproterenol Dose</p>
                  <p><bold>eDiscussion.</bold> Study Limitations</p>
                  <p>
eReferences
</p>
                </caption>
                <media xlink:href="jamapsychiatry-e214225-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p>
Trial Protocol
</p>
                </caption>
                <media xlink:href="jamapsychiatry-e214225-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
